Results 161 to 170 of about 39,918 (251)

S1 File - Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study

Jingjing Sun (543035), Hemalkumar B. Mehta (8811044), Jodi B. Segal (6254585), G. Caleb Alexander (7854044)   +3 more
openalex   +1 more source

Clinical Implications of Co‐administering Apixaban with Key Interacting Medications [PDF]

Nicholas Favatella, David Dalton, Wonkyung Byon, Samira Merali, Christian Klem   +4 more
openalex   +1 more source

Safety Profile of Warfarin and Apixaban for Deep Vein Thrombosis in Patients With Chronic Kidney Disease. [PDF]

Cureus
Kausar F, Nadeem O, Khalil A, Ahmad S, Ali W.   +4 more
europepmc   +1 more source

Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer

Alexander T. Cohen, Katherine Creeper, Raza Alikhan, Chaozer Er, Jean M. Connors, Menno V. Huisman, Andrés J. Muñoz Martín, Giorgio Vescovo, Rupert Bauersachs, Walter Ageno, Giancarlo Agnelli, Cecilia Becattini   +11 more
openalex   +2 more sources

Kosteneffektivität von Apixaban zur Verhinderung von Schlaganfällen bei Vorhofflimmern in Deutschland [PDF]

, 2013
Andreas Reimer, Oliver Schöffski
openalex   +1 more source

Which gastric cancer patients benefit more from apixaban compared to heparin?

Tripdatabase
openalex   +1 more source

Design, synthesis, and structure–activity relationship of novel and effective apixaban derivatives as FXa inhibitors containing 1,2,4-triazole/pyrrole derivatives as P2 binding element

, 2016
Yong Wang, Xiaoqing Sun, Di Yang, Zhuang Guo, Xuxu Fan, Minhua Nie, Feng Zhang, Yue Liu, Yue Li, Yulin Wang, Ping Gong, Yajing Liu, Yajing Liu, Yajing Liu   +13 more
openalex   +1 more source

Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States [PDF]

, 2016
Gregory Y.H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Amanda Bruno, Hemant Phatak   +7 more
openalex   +1 more source

Activated charcoal neutralization restores accurate Model for End-Stage Liver Disease and Child-Pugh scores in patients with cirrhosis on direct oral anticoagulant therapy. [PDF]

Res Pract Thromb Haemost
Habay C, Riescher Tuczkiewicz A, Ben Salah I, Trichet C, Gay J, Durand F, Rautou PE, Roux O, De Raucourt E.   +8 more
europepmc   +1 more source

Comparative Outcomes of Apixaban and Acenocoumarol in Advanced Chronic Kidney Disease and Atrial Fibrillation: A Retrospective Observational Study. [PDF]

J Clin Med
Suliman IL, Tuta LA, Panculescu FG, Alexandru A, Fasie D, Cimpineanu B, Cozaru GC, Popescu S, Enache FD, Manac I, Chisnoiu T, Alexandrescu L, Bordeianu I.   +12 more
europepmc   +1 more source